Gelatin and Bone Glue Market Size (2025 – 2030)

The Gelatin and Bone Glue Market was valued at USD 5.20 billion in 2024 and is projected to reach a market size of USD 6.77 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 4.5%.

Gelatin and bone glue are mainly collagen-based materials obtained from animal bones, skins, and connective tissues. Gelatin is widely used in pharmaceuticals, food processing, and medical applications because of its bonding, gelling, and stabilization properties. Bone glue is a natural adhesive that is valued for its strong bonding capabilities in woodworking, bookbinding, and surgical processes. These materials are biodegradable, renewable, and compatible with various substrates, suitable for use in both industrial and healthcare settings. The market has been shaped by innovations in biomedical engineering, increasing demand for natural adhesives, and applications in drug distribution systems. Pharmaceutical companies use gelatin in capsule production and wound care. Bone glue is being rapidly adopted in orthopedic surgery and dental procedures. The market is influenced by sustainability goals, regulatory standards, and consumer preference for clean-label products. Technological progress in extraction and purification has improved the quality and comprehensive use of the product. The increasing interest in minimally invasive surgery and regenerative medicine further supports the expansion of this market. Manufacturers are investing in research to develop plant-based options and enhance performance.

Key Market Insights:

• Globally, around 46 % of gelatine is prepared from porcine hide, 29.4 % from bovine split, 23.1 % from bones, and 1.5 % from other sources, including chicken.
• Approximately 80 % of the gelatine prepared in Europe is derived from porcine skins and 15 % from cattle split. The remaining 5 % is prepared from porcine and bovine bones and fish.
• The natural adhesives, including bone glue, represent more than 20% of total adhesive consumption, reflecting a strong shift toward biodegradable materials.
• Bone adhesive showed a 30% reduction in healing time for wrist fractures compared to traditional fixation methods.
• India and China together account for over 40% of global gelatin production, supported by livestock availability and expanding pharma manufacturing.
• Around 60% of industrial buyers now prioritize biodegradable adhesives over synthetic ones, especially in packaging, woodworking, and construction sectors.

Market Drivers:

Rising demand in healthcare and pharmaceuticals is primarily driving the Gelatin and Bone Glue Market.

Increasing use of gelatin in the pharmaceutical industry is a major market driver in this market. Gelatin is necessary in the production of soft and hard capsules, drug coatings, and wound dressings. Its bioactivity and safety profile make it suitable for medical use. Bone glue is gaining traction in orthopedic and dental surgery due to its strong adhesion and natural origin. Hospitals and clinics prefer these materials for minimally invasive procedures. The demand for biodegradable and non-toxic adhesives in healthcare continues to increase. Regulatory approval and clinical success support further adoption. This trend is expected to strengthen because health services are being modernized globally.

The growth in sustainable and natural adhesives is driving the Gelatin and Bone Glue Market.

The shift towards environmentally friendly products is driving demand for gelatin and bone glue. These materials are biodegradable and are obtained from renewable sources, which align with global sustainability goals. Industries like woodworking and packaging are replacing synthetic adhesives with natural options. Bone glue provides strong bonding without harmful chemicals, which makes it ideal for traditional crafts and green construction. Gelatin is also used in clean-label food products and cosmetics. Consumers are becoming aware of the origin and environmental impact of the product. This preference for natural ingredients supports market growth across multiple sectors. Manufacturers are responding with better formulations and ethical sourcing.

Market Restraints and Challenges:

One major restraint in the market is the ethical concern around animal-derived products. Gelatin and bone glue are obtained from livestock, which raises issues for vegetarian consumers and religious groups. Regulatory bodies apply strict standards to sourcing, processing, and labelling. Variability in the quality of raw materials can affect product stability. Additionally, plant-based options are gaining popularity, creating competition. Manufacturers should balance performance with ethical transparency. Supply chain disruption and the increasing cost of animal by-products also pose challenges. Addressing these concerns requires innovation, clear communication, and compliance with global rules to maintain consumer trust and market stability.

Market Opportunities:

The market offers strong opportunities in biomedical engineering and regenerative medicine. Gelatin is used in tissue scaffolds, drug delivery systems, and surgeries due to its biocompatibility. Bone glue is being used for bone regeneration and fracture repair. Research institutes and biotech firms are investing in collagen-based biomaterials. These applications offer better treatment and shorter recovery time. The demand for personal medical and advanced surgical solutions supports innovation. Partnership between medical equipment companies and research laboratories is accelerating product development. Gelatin and bone glue will play an important role in the next generation of remedies and equipment, with the development of the healthcare industry.

GELATIN AND BONE GLUE MARKET REPORT COVERAGE:

Gelatin and Bone Glue Market Segmentation:

Gelatin and Bone Glue Market Segmentation By Product Type:

• Gelatin
• Bone Glue
• Synthetic Bone Adhesives
• Natural Bone Adhesives
• Others

Gelatin is the dominating product in the gelatin and bone glue market, due to its essential role in pharmaceuticals, food, and cosmetics. Gelation’s gelling and stabilizing properties make it ideal for capsules and coatings. Gelatin is also used in desserts, dairy, and nutritional supplements. It is preferred for its safety, versatility, and natural origin. Pharmaceutical companies rely on gelatin for drug distribution systems. Food manufacturers use it for texture and shelf life. Its broad application keeps gelatin in high demand. The consistent performance and regulatory approval make it a major product type in the market.

Synthetic bone adhesives are growing at the fastest rate in the gelatin and bone glue market, due to increasing surgical procedures. These adhesives provide strong bonding and quick treatment. They are used in orthopedic and dental surgery. Hospitals prefer them to repair complex bones. Unlike traditional bone glue, synthetic types are more stable and adaptable. Synthetic bone adhesives reduce the risk of infection and shorten recovery time. Research in biomaterials is promoting innovation. Surgeons now use them in minimally invasive processes. the role of synthetic bone adhesives in modern medicine makes them the fastest-growing product segment, with the increasing popularity of synthetic adhesives in healthcare.

Gelatin and Bone Glue Market Segmentation By Source:

• Animal-based (bovine, porcine)
• Plant-based alternatives
• Fish-based
• Mixed origin

Animal-based products are the dominant source in the gelatin and bone glue market, due to sustainability and proven performance. Gelatin is mostly obtained from bovine and porcine collagen. These sources provide high-protein materials and strong binding properties. They are widely accepted in the food and pharmaceutical industries. Manufacturers prefer them for sustainability and cost-effectiveness. Regulatory bodies approve their use in capsules and coatings. Bone glue from animal sources is used in wooden work and surgery. Their long history of safe use supports market dominance. Despite moral concerns, animal-based products remain the most commonly used sources in the gelatin and bone glue market.

Plant-based alternatives are growing rapidly in the gelatin and bone glue market, due to ethical and dietary preferences. Consumers seek vegetarian and halal-certified products. Manufacturers are developing plant-rich gelatin options using algae and starch. These options are used in food, cosmetics, and supplements. Plant-based alternatives provide clean-label benefits and meet the sustainability goals. Regulatory support for plant-based alternatives is increasing. The demand for plant-based alternatives is increasing in areas with religious restrictions on non-veg products. Innovation in extraction and texture is improving the quality of the product. plant-based sources are growing rapidly with rising awareness. Their eco-friendly appeal makes them the fastest-growing source segment.

Gelatin and Bone Glue Market Segmentation By Application:

• Pharmaceuticals (capsules, coatings)
• Medical (orthopedic, dental, wound care)
• Food and Beverage
• Woodworking and Bookbinding
• Others

Pharmaceutical applications are dominating the gelatin and bone glue market, due to high gelatin use in drug delivery. Gelatin is used in capsules, tablets, and coatings. It helps release control and improve absorption. pharmaceutical manufacturers prefer it for safety and effectiveness. Bone glue is also used in surgical processes. Hospitals rely on these materials for wound care and tissue repair. Regulatory approval supports the pharmaceutical applications of bone glue. The increasing demand for advanced therapies and supplements is further driving this market growth. The prominent role of gelatin in healthcare keeps this segment dominating. Its versatility and proven results make pharmaceuticals the largest application area.

Medical applications are growing at the fastest rate in the gelatin and bone glue market, due to increasing surgery and an aging population. Bone glue is used in orthopedic and dental repair. It provides strong adhesion and rapid treatment. Gelatin is used in wound dressing and tissue scaffolds. Hospitals are adopting these materials for minimally invasive procedures. Research in regenerative medicine is promoting demand for this market. Doctors prefer natural adhesives for safety and biocompatibility. New products are entering the market with better performance. The medical use of gelatin and bone glue is increasing with the expansion of healthcare. This makes medical applications the fastest-growing section.

Gelatin and Bone Glue Market Segmentation: Regional Analysis:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

The North America region is leading the gelatin and bone glue market, due to advanced healthcare and high consumption. Pharmaceutical companies use gelatin in capsules and coatings. The hospitals perform surgery using bone glue and adhesive. The region has strong regulatory support and research facilities. Consumers prefer clean labels and natural products. Food and supplementary industries also use gelatin widely. Manufacturers invest in innovation and quality control of the gelatin and bone glue market. The US and Canada dominate the production and use of gelatin and bone glue. High awareness and investment support growth. These factors make North America the largest regional segment of the gelatin and bone glue market.

Asia-Pacific is growing at the fastest rate in the gelatin and bone glue market, due to rising healthcare and food demand. Countries such as China, India, and Japan are investing in medical infrastructure. Gelatin is used in traditional and modern medicine. Bone glue is gaining popularity in dental and orthopedic care. Food industries use gelatin in snacks and desserts. Plant-based options are also increasing in this area. Regulatory bodies support safe and ethical sourcing. The increasing population and urbanization in the Asia-Pacific region further boost consumption. Local manufacturers expand production and exports.

Gelatin and Bone Glue Market COVID-19 Impact Analysis:

The outbreak of COVID-19 disrupted supply chains and manufacturing operations in gelatin and bone glue markets. Lockdown affected the availability of raw materials and delayed the production program. The demand for healthcare has moved towards emergency care, which has reduced alternative processes using bone glue. However, gelatin drug applications remain stable due to continuous drug production. The pandemic highlighted the requirement of reliable, biocompatible materials in medical settings. Companies diversified their digital operations and sourcing strategies. Post-pandemic recovery is marked by renewed investment in healthcare infrastructure and durable materials. The market is gaining momentum with a focus on resilience and innovation.

Latest Trends and Developments:

Recent trends include the rise of plant-based gelatin options for vegetarian and halal markets. Innovations in gelatin extraction have improved purity and reduced processing time. Bone glue is being improved for rapid treatment and greater strength in surgical use. AI and automation are streamlining production and quality control. Companies are launching clean-label gelatin for food and nutraceuticals. Partnership between biotech firms and academic institutions is driving research in regenerative applications. Sustainability certificates and ethical sourcing are gaining importance. Digital platforms are helping manufacturers reach global buyers.

Key Players in the Market:

1. Chemence Medical, Inc.
2. LaunchPad Medical, Inc.
3. SetBone Medical Ltd.
4. Baxter International Inc.
5. Artivion, Inc.
6. BD (Becton, Dickinson and Company)
7. B. Braun Melsungen AG
8. Johnson & Johnson
9. Integra LifeSciences Holdings Corporation
10. Cohera Medical, Inc.

Latest Market News:

• December 2024: RevBio, Inc., announced that it has received FDA approval to expand its ongoing clinical trial to immediately fixate cranial flaps using TETRANITE®, the company’s bone adhesive biomaterial. The company also received reimbursement coverage from the Centers for Medicare and Medicaid for the use of TETRANITE to replace metal plates and screws.
• May 2025: RevBio Expands Globally into the United Kingdom with its Second Cranial Flap Fixation Clinical Trial for its Regenerative Bone Adhesive. This clinical trial is designed to demonstrate that TETRANITE can reintegrate these bone flaps with the surrounding bone to improve cosmesis, increase flap stability for patient comfort, and help prevent cerebrospinal fluid leaks, which can cause significant pain and lead to serious infections.